Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S.

Neuralink, the Elon Musk-owned brain-computer interface company, has received "breakthrough device" clearance from the FDA.

Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device.

The hybrid device achieves a record energy storage efficiency of 2.3% and a total solar utilization efficiency of 14.9%.

Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.

Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind ...

The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.

The FDA approval given to Musk's start-up Neuralink allows for human testing. A look at how Blindsight works & Neuralink’s ...

With Blindsight now receiving the FDA’s Breakthrough Device Designation, Neuralink looks set to push forward with technology ...

Elon Musk-owned neurotechnology firm Neuralink has received the U.S. FDA’s breakthrough device designation for its brain ...

Elon Musk's brain-chip company Neuralink has received the FDA’s "breakthrough device" designation for its experimental vision ...